Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

Myopathy breakthrough paves way for new treatments
Dr Charlotte Maile and Professor Richard Piercy.

RVC study reveals mechanisms that underlie form of 'tying-up'

New research has revealed the molecular mechanisms that underlie a common form of ‘tying-up’ in horses.

Tying-up, scientifically known as Type 1 Polysaccharide Storage Myopathy (PSSM1), is a common condition that damages equine muscle tissue.  

Animals affected by the condition have a mutation of a key enzyme (glycogen synthase) which is involved in energy metabolism in muscle.

They also suffer from a build-up of polysaccharide (a form of carbohydrate) and increased storage of glycogen. Horses that carry the condition are prone to ‘tying up and muscle weakness.

Until now, nobody knew the precise mechanism by which the mutation caused increased enzyme activity in muscles. But new research, published in the journal Biochim Biohys Acta, shows that the mutation leads to a change in the enzyme’s structure, leaving it permanently active.

This hyperactivity, the team explains, accounts for the increased muscle glycogen and the accumulation of polysaccharide.

Led by
Dr Charlotte Maile and Professor Richard Piercy of the RVC, the research was conducted by an international team of scientists from the University of Copenhagen, University of Minnesota, Indiana University School of Medicine and Liverpool John Moore’s University.

It is hoped that the breakthrough will enable the team to work towards improving treatments and management for this disorder, to improve the welfare of affected horses.

"PSSM1 is a very common disease, especially in some breeds. Finally we know the reason why these horses store excessive glycogen and polysaccharide in their muscles. Our goal now is to use this information in designing new treatments and management strategies,” said Professor Richard Piercy, Professor of Comparative Neuromuscular Disease.

Prof Richard Piercy added: “Managing horses that tie-up is hard, and some recommended treatments work poorly in some animals. By revealing the precise mechanism for this form of tying up, our work should make a real difference.

“Our hope is that by targeting specific approaches to the problem, rather than a ‘one treatment fits all’ - horse welfare will be improved allowing them to get back to exercise, which has to be good for the horse and their owner”.

Become a member or log in to add this story to your CPD history

Survey launched to investigate EHV

News Story 1
 Zoetis has launched a new survey to identify management techniques for Equine Herpes Virus (EHV).

EHV is a contagious, airborne virus that can cause respiratory problems and severe diseases in horses and ponies. It spreads among horses over short distances, direct contact and through shared equipment.

The survey will explore current knowledge and management practices with EHV in the UK. It is quick to complete and participants could win one of 10 equine first aid kits.

Complete the survey here

Click here for more...
News Shorts
WSAVA launches pet travel guidance factsheet

A new pet travel guidance factsheet for veterinary professionals and caregivers has been developed by the WSAVA in collaboration with the World Veterinary Association.

The Dog and Cat Welfare During Transport factsheet provides step-by-step guidance for all stages of a journey, from pre-travel checklists to post-travel care.

Brachycephalic breeds or animals prone to travel-related anxiety are given special focus in this guide, which also provides links to IATA container regulation and WSAVA vaccination guidelines.